SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,318,417 | -37.1% | 232,525 | -37.9% | 0.54% | -9.3% |
| Q4 2022 | $2,096,763 | -10.9% | 374,422 | +2.2% | 0.60% | -24.6% |
| Q3 2022 | $2,353,000 | +97.2% | 366,493 | +5.4% | 0.80% | +116.9% |
| Q2 2022 | $1,193,000 | -48.7% | 347,761 | +6.4% | 0.37% | -61.9% |
| Q1 2022 | $2,327,000 | -12.9% | 326,872 | +2.0% | 0.96% | -11.0% |
| Q4 2021 | $2,671,000 | +39.6% | 320,602 | +16.7% | 1.08% | 0.0% |
| Q3 2021 | $1,913,000 | -57.0% | 274,833 | +47.3% | 1.08% | -45.5% |
| Q2 2021 | $4,450,000 | +116.1% | 186,615 | +86.6% | 1.98% | +76.8% |
| Q1 2021 | $2,059,000 | +235.9% | 100,000 | +300.0% | 1.12% | +215.4% |
| Q4 2020 | $613,000 | – | 25,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |